StockData
National Health Investors Inc logo

National Health Investors Inc (NHI) stock analysis

NHINYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 15/30
$62.95−1.60 (-2.48%)

Close on Nov 13, 2026Market cap $3.09BP/E 4.4Yield 5.53%

StockData Score

Prices as of Nov 13, 2026How the score works

Value2Growth5Performance3Health1Dividend4

Solid15 of 30 checks passed

National Health Investors passes 15 of the 30 checks behind our score; 11 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
2/6
Growth
5/6
Past performance
3/6
Financial health
1/6
Dividend
4/6

What stands out

  • Revenue growing 10%+ a year

    Revenue grew 10.5% a year over the last three fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 26.8% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 374% over the last twelve months, against a 5-year average of -5.1% a year.

  • Low bankruptcy risk

    The Altman Z-score is 3.24; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Return on equity under 15%

    Return on equity was 39.1% over the last twelve months and averaged 8.7% over five years; we look for 15% on both.

  • Earnings shrank over 5 years

    Net income shrank 5.1% a year on average over the last five fiscal years.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • P/B above the industry

    National Health Investors's price-to-book of 1.48 is above the Miscellaneous Investing median of 1.20.

Valuation2/6

  • P/E below its 5-year median

    National Health Investors's P/E of 4.4 is below its own 5-year median of 24.2.

  • P/E below the industry

    National Health Investors's P/E of 4.4 is below the Miscellaneous Investing median of 26.5.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B above the industry

    National Health Investors's price-to-book of 1.48 is above the Miscellaneous Investing median of 1.20.

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth5/6

  • Revenue growing 10%+ a year

    Revenue grew 10.5% a year over the last three fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 26.8% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 374% over the last twelve months, against a 5-year average of -5.1% a year.

  • Growing faster than the industry

    Revenue grew 28.2% over the last twelve months; the Miscellaneous Investing median is 4.6%.

  • Guidance raised

    National Health Investors raised its 2026 FAD attributable to common stockholders outlook on Aug 10, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance3/6

  • Return on equity under 15%

    Return on equity was 39.1% over the last twelve months and averaged 8.7% over five years; we look for 15% on both.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity above the industry

    National Health Investors's return on equity of 39.1% is above the Miscellaneous Investing median of 2.8%.

  • Earnings shrank over 5 years

    Net income shrank 5.1% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 153% over the last twelve months, against a 5-year average of 36.5%.

  • Net margin above the industry

    National Health Investors's net margin of 153% is above the Miscellaneous Investing median of 10.3%.

Financial health1/6

  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt coverage

    Needs operating cash flow.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term liquidity

    The balance sheet is not split into current and non-current items.

  • Low bankruptcy risk

    The Altman Z-score is 3.24; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6

  • Pays a dividend

    National Health Investors paid dividends worth 5.9% of the share price over the last twelve months.

  • Yield above Treasuries

    The 5.9% yield is above the 4.7% on a 1-year Treasury.

  • Yield in the top quarter

    The top quarter of US dividend payers yield 3.8% or more; National Health Investors yields 5.9%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Covered by earnings

    Dividends take 25.5% of net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for National Health Investors. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 24.2
  • Miscellaneous Investing median 26.5

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$20.97M
Value traded per 1% price move
$19.07M

Downside

Low risk

Typical loss in a bad month
12.4%
Volatility (annualized)
25%
Sharpe ratio, 1 year
-0.89
Beta to the S&P 500 (5Y)
0.34

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Operating margin

–

Net margin

37.9%−17.8 pts over 5 years

See a number that looks wrong?